Genome wide analysis of acute myeloid leukemia reveal leukemia specific methylome and subtype specific hypomethylation of repeats

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Saied, Marwa H ^a,d   Marzec, Jacek ^a   Khalid, Sabah ^a   Smith, Paul ^a   Down, Thomas A ^b   Rakyan, Vardhman K ^c   Molloy, Gael ^a   Raghavan, Manoj ^a   Debernardi, Silvana ^a   Young, Bryan D ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

REPETITIVE DNA; DIPEPTIDYL PEPTIDASE; DPP6 PROTEIN, HUMAN; ID4 PROTEIN, HUMAN; INHIBITOR OF DIFFERENTIATION PROTEIN; NERVE PROTEIN; POTASSIUM CHANNEL; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SKIP PROTEIN, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; CYTOGENETICS; DNA METHYLATION; DNA SEQUENCE; DPP6 GENE; GENE ACTIVITY; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC REGULATION; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; ONCOGENE; PROMOTER REGION; PYROSEQUENCING; SPHKAP GENE; ACUTE DISEASE; CELL STRAIN HL 60; CLUSTER ANALYSIS; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; METHODOLOGY; MYELOID LEUKEMIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHORT INTERSPERSED REPEAT; TUMOR CELL LINE;

CUCURBITA;

ACUTE DISEASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE, TUMOR; CLUSTER ANALYSIS; CPG ISLANDS; DIPEPTIDYL-PEPTIDASES AND TRIPEPTIDYL-PEPTIDASES; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HL-60 CELLS; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEINS; LEUKEMIA, MYELOID; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POTASSIUM CHANNELS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SHORT INTERSPERSED NUCLEOTIDE ELEMENTS;

EID: 84859083304     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033213     Document Type: Article

References (71)

1. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, et al. (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92: 2322-2333.
2. Marcucci G, Haferlach T, Dohner H, (2011) Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications. J Clin Oncol 29: 475-486.
3. Meyer C, Kowarz E, Hofmann J, Renneville A, Zuna J, et al. (2009) New insights to the MLL recombinome of acute leukemias. Leukemia 23: 1490-1499.
4. Ernst T, Chase AJ, Score J, Hidalgo-Curtis CE, Bryant C, et al. (2010) Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat Genet 42: 722-726.
5. Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, et al. (2010) DNMT3A mutations in acute myeloid leukemia. N Engl J Med 363: 2424-2433.
6. Rodriguez-Paredes M, Esteller M, (2011) Cancer epigenetics reaches mainstream oncology. Nat Med 17: 330-339.
7. Laird PW, (2010) Principles and challenges of genome-wide DNA methylation analysis. Nat Rev Genet 11: 191-203.
8. von Bubnoff A, (2008) Next-generation sequencing: the race is on. Cell 132: 721-723.
9. Bock C, Tomazou EM, Brinkman AB, Muller F, Simmer F, et al. (2010) Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat Biotechnol 28: 1106-1114.
10. Rakyan VK, Down TA, Balding DJ, Beck S, (2011) Epigenome-wide association studies for common human diseases. Nat Rev Genet 12: 529-541.
11. Down TA, Rakyan VK, Turner DJ, Flicek P, Li H, et al. (2008) A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat Biotechnol 26: 779-785.
12. Feber A, Wilson GA, Zhang L, Presneau N, Idowu B, et al. (2011) Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors. Genome Res.
13. Chavez L, Jozefczuk J, Grimm C, Dietrich J, Timmermann B, et al. (2010) Computational analysis of genome-wide DNA methylation during the differentiation of human embryonic stem cells along the endodermal lineage. Genome Res 20: 1441-1450.
14. Ehrlich M, (2002) DNA methylation in cancer: too much, but also too little. Oncogene 21: 5400-5413.
15. Flanagan JM, Wild L, (2007) An epigenetic role for noncoding RNAs and intragenic DNA methylation. Genome Biol 8: 307.
16. Shen L, Kondo Y, Guo Y, Zhang J, Zhang L, et al. (2007) Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genet 3: 2023-2036.
17. Tibshirani R, Walther G, (2005) Cluster validation by prediction strength. Journal of Computational and Graphical Statistics 14: 511-528.
18. Yu L, Liu C, Vandeusen J, Becknell B, Dai Z, et al. (2005) Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nat Genet 37: 265-274.
19. Bennett LB, Schnabel JL, Kelchen JM, Taylor KH, Guo J, et al. (2009) DNA hypermethylation accompanied by transcriptional repression in follicular lymphoma. Genes Chromosomes Cancer 48: 828-841.
20. Kirwan M, Vulliamy T, Marrone A, Walne AJ, Beswick R, et al. (2009) Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia. Hum Mutat 30: 1567-1573.
21. Jaeger J, Koczan D, Thiesen HJ, Ibrahim SM, Gross G, et al. (2007) Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues. Clin Cancer Res 13: 806-815.
22. Lacana E, Maceyka M, Milstien S, Spiegel S, (2002) Cloning and characterization of a protein kinase A anchoring protein (AKAP)-related protein that interacts with and regulates sphingosine kinase 1 activity. J Biol Chem 277: 32947-32953.
23. Pyne NJ, Pyne S, (2010) Sphingosine 1-phosphate and cancer. Nat Rev Cancer 10: 489-503.
24. Beck S, Rakyan VK, (2008) The methylome: approaches for global DNA methylation profiling. Trends Genet 24: 231-237.
25. Kim JH, Dhanasekaran SM, Prensner JR, Cao X, Robinson D, et al. (2011) Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer. Genome Res 21: 1028-1041.
26. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, et al. (2009) The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 41: 178-186.
27. Koga Y, Pelizzola M, Cheng E, Krauthammer M, Sznol M, et al. (2009) Genome-wide screen of promoter methylation identifies novel markers in melanoma. Genome Res 19: 1462-1470.
28. Pai AA, Bell JT, Marioni JC, Pritchard JK, Gilad Y, (2011) A genome-wide study of DNA methylation patterns and gene expression levels in multiple human and chimpanzee tissues. PLoS Genet 7: e1001316.
29. Bird A, (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21.
30. Veyrieras JB, Kudaravalli S, Kim SY, Dermitzakis ET, Gilad Y, et al. (2008) High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet 4: e1000214.
31. Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, et al. (2010) Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466: 253-257.
32. Xin D, Hu L, Kong X, (2008) Alternative promoters influence alternative splicing at the genomic level. PLoS One 3: e2377.
33. Virtaneva K, Wright FA, Tanner SM, Yuan B, Lemon WJ, et al. (2001) Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci U S A 98: 1124-1129.
34. Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, et al. (2004) Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 350: 1617-1628.
35. Debernardi S, Lillington DM, Chaplin T, Tomlinson S, Amess J, et al. (2003) Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events. Genes Chromosomes Cancer 37: 149-158.
36. Wilson AS, Power BE, Molloy PL, (2007) DNA hypomethylation and human diseases. Biochim Biophys Acta 1775: 138-162.
37. Tong WG, Wierda WG, Lin E, Kuang SQ, Bekele BN, et al. (2010) Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact. Epigenetics 5: 499-508.
38. Figueroa ME, Lugthart S, Li Y, Erpelinck-Verschueren C, Deng X, et al. (2010) DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell 17: 13-27.
39. Khulan B, Thompson RF, Ye K, Fazzari MJ, Suzuki M, et al. (2006) Comparative isoschizomer profiling of cytosine methylation: the HELP assay. Genome Res 16: 1046-1055.
40. Kovanich D, van der Heyden MA, Aye TT, van Veen TA, Heck AJ, et al. (2010) Sphingosine kinase interacting protein is an A-kinase anchoring protein specific for type I cAMP-dependent protein kinase. Chembiochem 11: 963-971.
41. Shida D, Takabe K, Kapitonov D, Milstien S, Spiegel S, (2008) Targeting SphK1 as a new strategy against cancer. Curr Drug Targets 9: 662-673.
42. Kilbey A, Terry A, Jenkins A, Borland G, Zhang Q, et al. (2010) Runx regulation of sphingolipid metabolism and survival signaling. Cancer Res 70: 5860-5869.
43. Portela A, Esteller M, (2010) Epigenetic modifications and human disease. Nat Biotechnol 28: 1057-1068.
44. Choi SH, Worswick S, Byun HM, Shear T, Soussa JC, et al. (2009) Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer. Int J Cancer 125: 723-729.
45. Hoffmann MJ, Schulz WA, (2005) Causes and consequences of DNA hypomethylation in human cancer. Biochem Cell Biol 83: 296-321.
46. Roman-Gomez J, Jimenez-Velasco A, Agirre X, Cervantes F, Sanchez J, et al. (2005) Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia. Oncogene 24: 7213-7223.
47. Lee JY, Ji Z, Tian B, (2008) Phylogenetic analysis of mRNA polyadenylation sites reveals a role of transposable elements in evolution of the 3′-end of genes. Nucleic Acids Res 36: 5581-5590.
48. Mansour A, (2007) Epigenetic activation of genomic retrotransposons. Journal of Cell and Molecular Biology 6: 99-107.
49. Wolff EM, Byun HM, Han HF, Sharma S, Nichols PW, et al. (2010) Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet 6: e1000917.
50. Agrawal S, Unterberg M, Koschmieder S, zur Stadt U, Brunnberg U, et al. (2007) DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia. Cancer Res 67: 1370-1377.
51. Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, et al. (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115: 453-474.
52. Kakuda H, Sato T, Hayashi Y, Enomoto Y, Takayama J, et al. (1996) A novel human leukaemic cell line, CTS, has a t(6;11) chromosomal translocation and characteristics of pluripotent stem cells. Br J Haematol 95: 306-318.
53. Rehfeldt W, Hass R, Goppelt-Struebe M, (1991) Characterization of phospholipase A2 in monocytic cell lines. Functional and biochemical aspects of membrane association. Biochem J 276 (Pt 3): 631-636.
54. Hirose M, Minato K, Tobinai K, Shimoyama M, Watanabe S, et al. (1982) A novel monocytoid cultured cell line, P31/Fujioka, derived from acute monoblastic leukemia. Gann 73: 735-741.
55. Qian J, Bours V, Manischewitz J, Blackburn R, Siebenlist U, et al. (1994) Chemically selected subclones of the CEM cell line demonstrate resistance to HIV-1 infection resulting from a selective loss of NF-kappa B DNA binding proteins. J Immunol 152: 4183-4191.
56. Bargou RC, Mapara MY, Zugck C, Daniel PT, Pawlita M, et al. (1993) Characterization of a novel Hodgkin cell line, HD-MyZ, with myelomonocytic features mimicking Hodgkin's disease in severe combined immunodeficient mice. J Exp Med 177: 1257-1268.
57. Winter JN, Variakojis D, Epstein AL, (1984) Phenotypic analysis of established diffuse histiocytic lymphoma cell lines utilizing monoclonal antibodies and cytochemical techniques. Blood 63: 140-146.
58. Hsu MY, Meier F, Herlyn M, (2002) Melanoma development and progression: a conspiracy between tumor and host. Differentiation 70: 522-536.
59. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, et al. (2005) Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 37: 853-862.
60. Voelkerding KV, Dames SA, Durtschi JD, (2009) Next-generation sequencing: from basic research to diagnostics. Clin Chem 55: 641-658.
61. Holt KE, Teo YY, Li H, Nair S, Dougan G, et al. (2009) Detecting SNPs and estimating allele frequencies in clonal bacterial populations by sequencing pooled DNA. Bioinformatics 25: 2074-2075.
62. Langmead B, Trapnell C, Pop M, Salzberg SL, (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
63. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
64. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
65. Schulte JH, Marschall T, Martin M, Rosenstiel P, Mestdagh P, et al. (2010) Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma. Nucleic Acids Res 38: 5919-5928.
66. Allison DB, Gadbury GL, Heo MS, Fernandez JR, Lee CK, et al. (2002) A mixture model approach for the analysis of microarray gene expression data. Computational Statistics & Data Analysis 39: 1-20.
67. Ward JH, (1963) Hierarchical grouping to optimize an objective function. Journal of American Statistical Association 58: 236-244.
68. Tost J, Gut IG, (2007) DNA methylation analysis by pyrosequencing. Nat Protoc 2: 2265-2275.
69. Van der Auwera I, Yu W, Suo L, Van Neste L, van Dam P, et al. (2010) Array-based DNA methylation profiling for breast cancer subtype discrimination. PLoS One 5: e12616.
70. Barbacioru CC, Wang Y, Canales RD, Sun YA, Keys DN, et al. (2006) Effect of various normalization methods on Applied Biosystems expression array system data. BMC Bioinformatics 7: 533.
71. Abdul-Nabi AM, Yassin ER, Varghese N, Deshmukh H, Yaseen NR, (2010) In vitro transformation of primary human CD34+ cells by AML fusion oncogenes: early gene expression profiling reveals possible drug target in AML. PLoS One 5: e12464.